SMARCA4 and ovarian carcinoma: Promotion of HR repair is facilitated by SMARCA4 (Kurashima et al., 2020) and in the ovary, alterations in SMARC4 have been associated with ovarian carcinomas (Agaimy et al., 2015; Moes-Sosnowska et al., 2015).